PTC Therapeutics, Inc. (PTCT) is a publicly traded Healthcare sector company. As of August 27, 2026, PTCT trades at $72.00 with a market cap of $6.13B and a P/E ratio of -112.60. PTCT moved -0.95% today. Year to date, PTCT is -5.28%; over the trailing twelve months it is +46.97%. Its 52-week range spans $35.95 to $90.87. Analyst consensus is buy with an average price target of $99.09. Rallies surfaces PTCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PTCT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PTCT recently traded at $72.00. Market cap is $6.13B. P/E ratio is -112.60. Revenue is $1.01B.
| Metric | Value |
|---|---|
| Price | $72.00 |
| Market Cap | $6.13B |
| P/E Ratio | -112.60 |
| EPS | $-0.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $90.87 |
| 52-Week Low | $35.95 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.01B |
| Net Income | $-38.38M |
| Gross Margin | 0.00% |
11 analysts cover PTCT: 0 strong buy, 9 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $99.09.